n/a
Article Publish Status: FREE
Abstract Title:

Genistein Improves Liver Damage in Male Mice Exposed to Morphine.

Abstract Source:

Chin Med J (Engl). 2018 Jul 5 ;131(13):1598-1604. PMID: 29941714

Abstract Author(s):

Mohammad Reza Salahshoor, Shiva Roshankhah, Payman Hosseni, Cyrus Jalili

Article Affiliation:

Mohammad Reza Salahshoor

Abstract:

Background: Morphine is commonly used to treat severe pain. This substance is significantly metabolized in the liver and causes disturbing effects. Genistein is an isoflavone and has antioxidant properties. The aim of this study was to evaluate the effects of genistein against morphine damages on mouse liver.

Methods: Between May 2017 and March 2018, 48 male mice were divided into six groups (n = 8 in each group). Various doses of genistein (25 and 50 mg/kg) and morphine plus genistein (25 and 50 mg/kg) were administered intraperitoneally to 48 male mice for 20 consequent days. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), serum nitric oxide (NO) levels, liver weight, and the diameter of hepatocytes and central hepatic vein were studied and compared using one-way analysis of variance.

Results: Morphine administration significantly increased the mean diameter of the central hepatic vein (22.76± 1.9 μm vs. 15.04 ± 0.60 μm, χ= 21.814, P = 0.001) and hepatocytes (3.03± 0.10 μm vs. 1.10 ± 0.05 μm, χ= 9.873, P = 0.001) respectively, blood serum NO level (38.00%± 2.09% vs. 18.72% ± 4.40%, χ= 20.404, P<0.001), liver enzyme level (AST: 111.80± 5.10 ng/ml vs. 81.93 ± 2.20 ng/ml, χ= 32.201, P<0.0001; ALT: 45.14± 4.10 ng/ml vs. 35.49 ± 2.50 ng/ml, χ= 18.203, P<0.0001; and ALP: 3.28± 0.20 ng/ml vs. 2.14 ± 0.10, χ= 5.04, P<0.0001, respectively), and decreased liver weight (18.50± 0.90 g vs. 27.15 ± 0.50 g, χ= 22.415, P = 0.001) compared to saline group (0.535-0.750, P<0.0001). However, administration of genistein plus morphine significantly enhanced liver weight (25 mg/kg: 21.15± 2.13 g vs. 18.50 ± 0.90 g, χ= 19.251, P<0.0001; 50 mg/kg: 21.20± 1.00 g vs. 18.5 ± 0.9 g, χ= 19.502, P<0.0001, respectively) and reduced the mean diameter of hepatocyte (25 mg/kg: 2.17± 0.30 μm vs. 3.03 ± 0.10 μm, χ= 22.780, P = 0.001; 50 mg/kg: 2.01± 0.20 μm vs. 3.03 ± 0.10 μm χ= 7.120, P = 0.001, respectively), central hepatic vein (25 mg/kg: 19.53± 1.00 μm vs. 22.76 ± 1.90 μm, χ= 20.681, P = 0.001; 50 mg/kg: 19.44± 1.20 μm vs. 22.76 ± 1.90 μm, χ= 18.451, P = 0.001, respectively), AST (25 mg/kg: 95.40± 5.20 ng/ml vs. 111.80 ± 5.010 ng/ml, P<0.0001; 50 mg/kg: 90.78± 6.00 ng/ml vs. 111.80 ± 5.10 ng/ml, χ= 17.112, P<0.0001, respectively), ALT (25 mg/kg: 35.78± 5.01 ng/ml vs. 45.14 ± 4.10 ng/ml, χ= 15.320, P<0.0001; 50 mg/kg: 33.78± 2.60 ng/ml vs. 45.14 ± 4.10 ng/ml, χ= 14.023, P<0.0001, respectively), ALP (25 mg/kg: 2.35± 0.30 ng/ml vs. 3.28 ± 0.20 ng/ml, χ= 4.101, P<0.0001; 50 mg/kg: 2.34± 0.10 ng/ml vs. 3.28 ± 0.20 ng/ml, χ= 2.033, P<0.0001, respectively), and NO levels (25 mg/kg: 25.92%± 2.30% vs. 38% ± 2.09%, χ= 17.103, P<0.0001; 50 mg/kg: 24.74%± 4.10% vs. 38% ± 2.09%, χ= 25.050, P = 0.001, respectively) compared to morphine group.

Conclusion: It seems that genistein administration might improve liver damages induced by morphine in mice.

Study Type : Animal Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.